PRIMECAP MANAGEMENT CO/CA/ - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,139 filers reported holding NOVARTIS A G in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRIMECAP MANAGEMENT CO/CA/ ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$1,486,662,183
-1.9%
14,595,152
-2.8%
1.26%
-0.9%
Q2 2023$1,514,727,214
+0.2%
15,010,675
-8.6%
1.27%
-3.9%
Q1 2023$1,511,287,220
-3.1%
16,427,035
-4.5%
1.32%
-7.7%
Q4 2022$1,559,919,514
+17.6%
17,194,880
-1.5%
1.43%
+11.2%
Q3 2022$1,326,614,000
-10.9%
17,453,150
-0.9%
1.28%
-3.5%
Q2 2022$1,488,073,000
-4.6%
17,604,080
-1.0%
1.33%
+13.0%
Q1 2022$1,560,610,000
-1.8%
17,784,730
-2.1%
1.18%
+7.0%
Q4 2021$1,588,944,000
+1.9%
18,165,590
-4.7%
1.10%0.0%
Q3 2021$1,558,862,000
-11.4%
19,061,650
-1.1%
1.10%
-6.9%
Q2 2021$1,759,276,000
+0.2%
19,281,850
-6.1%
1.18%
-3.5%
Q1 2021$1,756,084,000
-14.7%
20,543,800
-5.8%
1.22%
-19.9%
Q4 2020$2,059,089,000
+4.9%
21,805,450
-3.4%
1.53%
-5.5%
Q3 2020$1,962,769,000
-3.4%
22,570,940
-3.0%
1.62%
-7.2%
Q2 2020$2,032,163,000
+2.6%
23,267,270
-3.2%
1.74%
-10.2%
Q1 2020$1,981,137,000
-17.9%
24,028,340
-5.7%
1.94%
+11.1%
Q4 2019$2,411,977,000
+8.7%
25,472,350
-0.3%
1.75%
-1.5%
Q3 2019$2,219,400,000
-5.1%
25,539,700
-0.3%
1.78%
+2.6%
Q2 2019$2,339,147,000
+2.0%
25,617,640
+7.4%
1.73%
+2.5%
Q1 2019$2,293,633,000
+16.8%
23,857,216
+4.2%
1.69%
+6.1%
Q4 2018$1,963,953,000
+2.5%
22,887,231
+2.9%
1.59%
+23.0%
Q3 2018$1,916,347,000
+14.6%
22,241,721
+0.5%
1.29%
+4.4%
Q2 2018$1,671,788,000
-5.2%
22,131,158
+1.4%
1.24%
-6.4%
Q1 2018$1,764,023,000
-4.0%
21,818,472
-0.3%
1.32%
-6.1%
Q4 2017$1,837,937,000
-2.5%
21,890,624
-0.3%
1.41%
-9.7%
Q3 2017$1,885,675,000
+2.2%
21,964,764
-0.6%
1.56%
-1.5%
Q2 2017$1,844,205,000
+14.5%
22,094,224
+1.8%
1.58%
+8.3%
Q1 2017$1,611,199,000
+4.1%
21,693,804
+2.1%
1.46%
-4.0%
Q4 2016$1,547,619,000
-4.7%
21,246,828
+3.4%
1.52%
-6.0%
Q3 2016$1,623,215,000
-5.6%
20,557,433
-1.3%
1.62%
-11.5%
Q2 2016$1,718,808,000
+13.3%
20,831,508
-0.5%
1.83%
+16.3%
Q1 2016$1,516,811,000
-15.1%
20,938,858
+0.8%
1.57%
-13.9%
Q4 2015$1,786,888,000
-6.6%
20,768,108
-0.2%
1.83%
-14.0%
Q3 2015$1,913,361,000
-12.1%
20,815,508
-6.0%
2.12%
-0.8%
Q2 2015$2,177,037,000
-0.4%
22,137,858
-0.2%
2.14%
+0.2%
Q1 2015$2,186,836,000
+6.5%
22,176,613
+0.0%
2.14%
+2.6%
Q4 2014$2,054,150,000
-1.9%
22,168,678
-0.3%
2.08%
-7.1%
Q3 2014$2,093,399,000
-3.0%
22,239,448
-6.7%
2.24%
-5.2%
Q2 2014$2,158,800,000
+5.7%
23,846,236
-0.7%
2.36%
+2.3%
Q1 2014$2,041,720,000
-4.9%
24,014,586
-10.1%
2.31%
-10.5%
Q4 2013$2,147,810,000
+4.3%
26,720,705
-0.5%
2.58%
-4.8%
Q3 2013$2,059,705,000
+7.6%
26,850,538
-0.8%
2.71%
-1.0%
Q2 2013$1,914,303,00027,072,5882.74%
Other shareholders
NOVARTIS A G shareholders Q4 2021
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders